Cargando…
Improving Small Intestinal Motility in Experimental Acute Necrotising Pancreatitis by Modulating the CPI-17/MLCP Pathway Using Chaiqin Chengqi Decoction
Protein kinase C-potentiated inhibitor protein of 17 kDa (CPI-17), a specific inhibitor of myosin light-chain phosphatase (MLCP) regulated by proinflammatory cytokines, is central for calcium sensitisation. We investigated the effects of chaiqin chengqi decoction (CQCQD) on the CPI-17/MLCP pathway i...
Autores principales: | Lin, Ziqi, Zhang, Chenlong, Zhang, Xiaoxin, Shi, Na, Wen, Yongjian, Han, Chengxia, Du, Dan, Liu, Tingting, Jin, Tao, Deng, Lihui, Jiang, Kun, Yang, Xiaonan, Guo, Jia, Philips, Anthony, Sutton, Robert, Windsor, John A., Huang, Wei, Xue, Ping, Xia, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035521/ https://www.ncbi.nlm.nih.gov/pubmed/32104199 http://dx.doi.org/10.1155/2020/9189457 |
Ejemplares similares
-
Retracted: Improving Small Intestinal Motility in Experimental Acute Necrotising Pancreatitis by Modulating the CPI-17/MLCP Pathway Using Chaiqin Chengqi Decoction
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2021) -
Transcriptomics and Network Pharmacology Reveal the Protective Effect of Chaiqin Chengqi Decoction on Obesity-Related Alcohol-Induced Acute Pancreatitis via Oxidative Stress and PI3K/Akt Signaling Pathway
por: Yang, Xinmin, et al.
Publicado: (2022) -
AGI grade-guided chaiqin chengqi decoction treatment for predicted moderately severe and severe acute pancreatitis (CAP trial): study protocol of a randomised, double-blind, placebo-controlled, parallel-group, pragmatic clinical trial
por: Chen, Zhiyao, et al.
Publicado: (2022) -
Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study
por: Huang, Zhipeng, et al.
Publicado: (2021) -
Study on Mechanism of Jiawei Chaiqin Wendan Decoction in Treatment of Vestibular Migraine Based on Network Pharmacology and Molecular Docking Technology
por: Liu, Menglin, et al.
Publicado: (2021)